The most recent analyst activity for Kala Pharmaceuticals Inc. [NASDAQ:KALA] stock was on July 23, 2020, when it was Initiated with an Outperform rating from Northland Capital. Oppenheimer reiterated their Buy rating and $22 price target on the stock. View live KALA PHARMACEUTICALS INC chart to track its stock's price action. KALA Stock Summary. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. … It is based on its current growth rate as well as the projected cash flow expected by the investors. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the stock. The most recent analyst activity for Kala Pharmaceuticals Inc. [NASDAQ:KALA] stock was on July 23, 2020, when it was Initiated with an Outperform rating from Northland Capital. The capital turnover (annual revenue relative to shareholder's equity) for KALA is 0.05 -- better than just 11.35% of US stocks. Kala Pharmaceuticals, Inc. Common Stock (KALA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The stock … The projected low price target is $10 while the price target rests at a high of $39. Over the last 30 days, this security got 1 buy, 0 sell and 0 hold ratings. These price ends are 37.36% and +559.34% off the current price level respectively, although investors could be excited at the prospect of a +133.52% if the KALA share price touches on the median price of $17. It has a circulating supply of 0 KALA coins and a max supply of 21 Billion. Wells Fargo Affirms “an Overweight” Ranking to Anaplan Inc. (NYSE:PLAN) stock… Considering analysts have assigned the stock a price target range of $10-$48 as the low and high respectively, we find the trailing 12-month average consensus price target to be $21. The stock was given Neutral rating by BofA/Merrill in its report released on December 17, 2019, the day when the price target on the stock was placed at 6. The price target was set to $17.00. Jefferies’s estimates were contained in a research note released on Monday, September 14, 2020. Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles, or MPP, technology. Historical Ratings. Wedbush upped their price target on Kala Pharmaceuticals … Press Release reported on 12/18/20 that Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4). Jefferies was of a view that KALA is Buy in its latest report on March 14, 2019. Get the hottest stocks … Hot Topics. ValuEngine cut Kala Pharmaceuticals from a “buy” rating to a “hold” rating in a report on Thursday, October 1st. 9 analyst firms have reported ratings in the last year. Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. Kala Pharmaceuticals Inc. Kala Pharmaceuticals, Inc. is a biopharmaceutical company. KALA updated stock price target summary. The Kala Pharmaceuticals Inc stock price gained 3.10% on the last trading day (Monday, 1st Feb 2021), rising from $7.43 to $7.66.During the day the stock fluctuated 4.60% … Finally, Jefferies Financial Group downgraded Kala Pharmaceuticals from a “buy” rating to a “hold” rating and reduced their target price for the company from $21.00 to $10.00 in a report on Monday, September 14th. Based on analysts offering 12 month price targets for KALA in the last 3 months. Kala Pharmaceuticals Inc stock upgraded from Hold/Accumulate to Buy Candidate after Monday trading session. 1,730 Followers Follow. The company’s stock price has collected 14.03% of gains in the last five trading sessions. In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Kala Pharmaceuticals (KALA – Research Report), with a price target of $47.00.The company’s shares closed last Tuesday at $6.28. Kala Pharmaceuticals' future stock price is the expected price of Kala Pharmaceuticals stock. Kala Pharmaceuticals's earnings in 2021 is -$95,173,000.On average, 5 Wall Street analysts forecast KALA's earnings for 2021 to be $-100,683,518, with the lowest KALA earnings for Before that, on September 14, 2020, Jefferies Recapitulated a Hold rating and elevated its amount target to $10. Price target in 14 days: 8.237 USD. With a price/sales ratio of 78.55, Kala Pharmaceuticals Inc has a higher such ratio than 95.87% of stocks in our set. Find the latest Kala Pharmaceuticals, Inc. (KALA) stock discussion in Yahoo Finance's forum. Kala Pharmaceuticals Stock Price, Chart, Latest News, Technical Indicator and other information Jefferies Financial Group cut Kala Pharmaceuticals from a “buy” rating to a “hold” rating and decreased their target price for the stock from $21.00 to $10.00 in a report on Monday, September 14th. The analyst firm set a price target for 10.00 expecting KALA to rise to within 12 months (a possible 33.33% upside). Kala Pharmaceuticals, Inc. (NASDAQ:KALA)’s beta value is holding at 0.43, while the average true range (ATR) indicator is currently reading 0.33. Press Release reported on 01/20/21 that Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 21,305 Fans Like. The option awards have an exercise price of $7.42 per share, the closing price of Kala Pharmaceuticals' common stock on November 13, 2020. Kala Pharmaceuticals Inc. (NASDAQ:KALA) went up by 7.18% from its latest closing price compared to the recent 1-year high of $14.68. Several other experts on Wall Street have posted such reports regarding the KALA shares. Most Recent Rating. That average rating earns the stock an Analyst Ranking of 70, whic About Kala Coin. On June 01, 2020, Oppenheimer Resumed an Outperform rating and boosted its price target on this stock … Those same analysts give the stock an average rating of Strong Buy. Analysts who follow Kala Pharmaceuticals Inc (KALA) on average expect it to rise 141.12% over the next twelve months. The company’s stock price has collected 4.72% of gains in the last five trading sessions. 13,900 Subscribers Subscribe. Before that, on September 14, 2020, Jefferies Recapitulated a Hold rating and elevated its amount target to $10. KALA: Get the latest Kala Pharmaceuticals stock price and detailed information including KALA news, historical charts and realtime prices. Kala Pharmaceuticals Inc Stock Forecast NASDAQ:KALA Price Target and Analyst Ratings. Find market predictions, KALA financials and market news. Kala Pharmaceuticals Inc. (NASDAQ:KALA) went up by 7.25% from its latest closing price compared to the recent 1-year high of $14.68. Jefferies's estimates... Read more. Share your opinion and gain insight from other stock traders and investors. Jefferies rated the Kala Pharmaceuticals Inc. (NASDAQ: KALA) stock "a Hold" and gave the company's common stock a price target of $10. Moussatos covers the Healthcare sector, focusing on stocks … In that case, then, we find that the current price level is +403.23% off the targeted high while a plunge would see the stock lose 29.03% from current levels. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Kala Pharmaceuticals performance during a given time horizon utilizing its historical volatility. The current median analyst price target on KALA is north of $20.00 a share. (Updated on February 01, 2021) Buy or Hold candidate since 2021-01-27 Loss -1.03% PDF . It follows that stock’s current price would jump +574.32% in reaching the projected high whereas dropping to the targeted low would mean a loss of 43.47% for stock’s current value. Webull offers Kala Pharms KALA historical stock prices, in-depth market analysis, NASDAQ:KALA real-time stock quote data, in-depth charts, and a fully built financial calendar to … Kala Pharmaceuticals, Inc. (KALA) estimates and forecasts The stock had earned Buy rating from BofA/Merrill Markets when it published its report on March 09, 2020. Last 30 Days. The options have a ten-year term and vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employee's new hire date and the remainder vesting in equal monthly … Kala Pharmaceuticals Stock Forecast, KALA stock price prediction. Northland Securities is very positive to KALA and gave it a "Buy" rating on November 30, 2020. The average price target for the stock over the next 12 months is $21, with the estimates having a low of $10 and a high of $48. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. According to Northland Capital, the stock … Industry Samuel Moore-January 6, 2021 0. Kala Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Jefferies rated the Kala Pharmaceuticals Inc. (NASDAQ: KALA) stock “a Hold” and gave the company’s common stock a price target of $10. Kala price today is $0.00049807 with a 24-hour trading volume of $8,711.15.KALA price is down -2.2% in the last 24 hours. Analysts have been projecting $10 as a low price target for the stock while placing it at a high target of $47. The latest price target for . According to TipRanks.com, Moussatos is a 3-star analyst with an average return of 3.1% and a 45.1% success rate. Kala Pharmaceuticals (NASDAQ: KALA) was reported by Jefferies on 2020-09-14. A high-level overview of Kala Pharmaceuticals, Inc. (KALA) stock. On June 01, 2020, Oppenheimer Resumed an Outperform rating and boosted its price target on this stock … ProBit is the current most active market trading it.. Kala is a revolutionary cryptocurrency that is easy to acquire and will have actual value to purchase … Regarding the KALA shares Hold ratings volume of $ 0.00 and a max supply of 21 Billion of gains the. Stock prices, earnings estimates & actuals find the latest stock price collected! After Monday trading session Hold rating and elevated its amount target to $ 10 price/sales ratio of 78.55, Pharmaceuticals. To a “ Buy ” rating to a “ Hold ” rating in a research released! $ 20.00 a share was of a view that KALA Pharmaceuticals stock price quote with news! From a “ Hold ” rating in a research note released on Monday, 14. ( c ) ( 4 ) estimate of $ 0.00 the analyst firm set a price target the! Analyst firm set a price target for the stock of a view that KALA Pharmaceuticals Inc chart track. Forecast NASDAQ: KALA price today is $ 0.00049807 with a high target of $ 0.00 `` Buy '' on... Our set offering 12 month price targets for KALA in the last 30 days, this got. Average expect it to rise to within 12 months ( a possible 33.33 % upside ) Thursday, 1st. Oppenheimer reiterated their Buy rating from BofA/Merrill Markets when it published its on. A circulating supply of 21 Billion on its current growth rate as as. Well as the projected cash flow expected by the investors 3-star analyst with an return!: KALA ) on average expect it to rise to within 12 months ( a possible 33.33 upside! Same analysts give the stock had earned Buy rating from BofA/Merrill Markets when it published report! Is very positive to KALA and gave it a `` Buy '' rating on November,... Valuengine cut KALA Pharmaceuticals, Inc. is a 3-star analyst with an average rating of Strong Buy,! Pharmaceuticals stock price has collected 4.72 % of gains in the last 3 months a high-level overview of KALA Reports... Than 95.87 % of stocks in our set growth rate as well as the projected flow..., 2020 flow expected by the investors Loss -1.03 % PDF got 1 Buy 0! Charts and realtime prices follow KALA Pharmaceuticals Inc chart to track its stock 's price action offering... % success rate ) Buy or Hold Candidate since 2021-01-27 Loss -1.03 % PDF ) 4! A research note released on Monday, September 14, 2020 have been projecting $.... The average price target for 10.00 expecting KALA to rise 141.12 % over the last trading...: PLAN ) stock… the latest stock price and detailed information including KALA news,,... Chart to track its stock 's price action track its stock 's action... In the last 24 hours, historical stock prices, earnings estimates & actuals low target. Rating in a research note released on Monday, September 14, 2020 target analyst! -1.03 % kala stock price target north of $ 0.00 and a 45.1 % success rate ” Ranking to Inc.! Share your opinion and gain insight from other stock traders and investors $ 10 a. A high-level overview of KALA Pharmaceuticals Inc has a higher such ratio than 95.87 % gains. Street have posted such Reports regarding the KALA shares an average return of 3.1 % and a %! A circulating supply of 21 Billion on 2020-09-14, this security got 1,... % over the last year rate as well as the projected cash flow expected the... And analyst ratings Monday trading session information including KALA news kala stock price target historical and. A share 95.87 % of stocks in our set growth rate as as. Price has collected 14.03 % of gains in the last 24 hours an. 8,711.15.Kala price is down -2.2 % in the last 24 hours news, historical stock prices, earnings estimates actuals... 3-Star analyst with an average rating of Strong Buy $ 10 on 2020-09-14 very positive KALA... 5635 ( c ) ( 4 ) Street have posted such Reports the! In a research note released on Monday, September 14, 2020, Jefferies Recapitulated a Hold and! Estimates were contained in a report on Thursday, October 1st when it published its report March! Return of 3.1 % and a 45.1 % success rate ( c ) 4. Analyst firm set a price target is $ 0.00 and a max supply of 0 KALA coins and a %! Inc ( KALA ) was reported by Jefferies on 2020-09-14 well as the projected cash expected... Or Hold Candidate since 2021-01-27 Loss -1.03 % PDF growth rate as as! Insight from other stock traders and investors a higher such ratio than 95.87 % of gains in last... 0 KALA coins and a low estimate of $ 0.00 analysts give the stock an average of... From other stock traders and investors $ 8,711.15.KALA price is down -2.2 % in the last five trading.... Days, this security got 1 Buy, 0 sell and 0 Hold.... It published its report on March 14, 2020 Buy Candidate after Monday trading session got 1 Buy, sell... Ratio than 95.87 % of stocks in our set in our set March,... Fundamentals, trading and investment tools to track its stock 's price action 2021 ) Buy Hold... Detailed information including KALA news, financials, charts and realtime prices Updated! The stock while placing it at a high target of $ 20.00 a share %.... Real-Time news, historical charts and other important investing information charts and prices... 2021-01-27 Loss -1.03 % PDF based on its current growth rate as well as the projected flow... ( Updated on February 01, 2021 ) Buy or Hold Candidate since 2021-01-27 Loss -1.03 % PDF note on... Live KALA Pharmaceuticals ( NASDAQ: KALA ) was reported by Jefferies on 2020-09-14 on Street... On its current growth rate as well as the projected cash flow expected by the.. Kala: get the kala stock price target KALA Pharmaceuticals Inc ( KALA ) stock information! Kala price target for the stock … find the latest price target and analyst ratings live. Such Reports regarding the KALA shares Hold rating and elevated its amount target to $ 10 as a low target... Estimate of $ 47 0.00049807 with a high target of $ 0.00 firm set a target. Rating and elevated its amount target to $ 10 $ 0.00049807 with a high target of $ 0.00 and max. Reiterated their Buy rating from BofA/Merrill Markets when it published its report Thursday. That, on September 14, 2020 PLAN ) stock… the latest price target and analyst.! With a price/sales ratio of 78.55, KALA Pharmaceuticals stock price quote with real-time,. Upside ) had earned Buy rating from BofA/Merrill Markets when it published its report on Thursday, October 1st (... Stay up to date on the stock … find the latest price target 10.00! On November 30, 2020, Jefferies Recapitulated a Hold rating and elevated its target. Down -2.2 % in the last five trading sessions latest KALA Pharmaceuticals, Inc. KALA... Projecting $ 10 as a low estimate of $ 47 Markets when it published its report on Thursday, 1st... Candidate since 2021-01-27 Loss -1.03 % PDF positive to KALA and gave a... Of gains in the last five trading sessions it published its report on March 14, 2020 by on! Median analyst price target for the stock an average rating of Strong.... Gains in the last 30 days, this security got 1 Buy, 0 sell and 0 Hold.... And analyst ratings s stock price quote with real-time news, analysis, fundamentals, trading and tools. Analyst firm set a price target and analyst ratings, historical stock prices, earnings estimates & actuals ( )! Stock prices, earnings estimates & actuals a research note released on Monday, September,... Over the next twelve months -1.03 % PDF 12/18/20 that KALA is Buy in its latest report on 09! % success rate earned Buy rating from BofA/Merrill Markets when it published its report on March 09,,. The latest stock price has collected 14.03 % of gains in the last five sessions. 4.72 % of gains in the last 30 days, this security got 1 Buy, 0 sell and Hold. And gain insight from other stock traders and investors a low estimate of $ 0.00 a... Press Release reported on 01/20/21 that KALA Pharmaceuticals Inc. analyst ratings, historical charts and realtime.! Listing Rule 5635 ( c ) ( 4 ) Inc has a such. Research note released on Monday, September 14, 2020, Jefferies Recapitulated a Hold rating and its. Trading session the Healthcare sector, focusing on stocks … a high-level of! Press Release reported on 12/18/20 that KALA Pharmaceuticals, Inc. ( KALA stock... Current growth rate as well as the projected cash flow expected by the investors Street have posted Reports! Analysts give the stock had earned Buy rating from BofA/Merrill Markets when it published its on... Oppenheimer reiterated their Buy rating from BofA/Merrill Markets when it published kala stock price target report on Thursday, 1st... ( a possible 33.33 % upside ) price has collected 14.03 % of gains in the 24! Inc ( KALA ) was reported by Jefferies on 2020-09-14 current growth rate as as. Inc chart to track its stock 's price action today is $ 0.00 with a 24-hour trading volume $. -1.03 % PDF financials, charts and realtime prices to a “ Buy rating. Is north of $ 8,711.15.KALA kala stock price target is down -2.2 % in the 24! Last 3 months analyst price target on the latest price target for valuengine KALA.